Therapeutic strategies for durable response in plasma cell granulomas in the central nervous system

Ann Hematol. 2019 Apr;98(4):1027-1029. doi: 10.1007/s00277-018-3490-7. Epub 2018 Sep 3.

Authors

Ameet Patel¹, Mehmet H Kocoglu², Akash Kaul³

Affiliations

¹ Department of Medicine, University of Maryland Medical Center, 22 S Greene St, Baltimore, MD, 21201, USA. ameetpatel@umm.edu.
² Division of Hematology/Oncology, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center, Baltimore, MD, USA.
³ American University Integrative Sciences, Tucker, GA, USA.

PMID: 30178192
DOI: 10.1007/s00277-018-3490-7

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Anaplastic Lymphoma Kinase* / genetics
Anaplastic Lymphoma Kinase* / metabolism
Brain Neoplasms / diagnostic imaging
Brain Neoplasms / drug therapy
Brain Neoplasms / enzymology
Brain Neoplasms / genetics
Granuloma, Plasma Cell* / diagnostic imaging
Granuloma, Plasma Cell* / drug therapy
Granuloma, Plasma Cell* / enzymology
Granuloma, Plasma Cell* / genetics
Humans
Male
Middle Aged
Neoplasm Proteins* / genetics
Neoplasm Proteins* / metabolism
Neoplasms, Muscle Tissue* / diagnostic imaging
Neoplasms, Muscle Tissue* / drug therapy
Neoplasms, Muscle Tissue* / enzymology
Neoplasms, Muscle Tissue* / genetics

Substances

Neoplasm Proteins
ALK protein, human
Anaplastic Lymphoma Kinase